PerkinElmer Receives AOAC INTERNATIONAL First Action Official Methods of Analysis (OMA) Status for Solus One Salmonella Assay
PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today announced its Solus One™ Salmonella assay and methods have been granted First Action Official Methods of Analysis℠ (OMA) status, number 2020.03, from AOAC INTERNATIONAL (Association of Official Analytical Collaboration).
The Solus One Salmonella assay, which previously received ISO 16140 and AOAC Performance Tested Methods℠ (PTM) certification, detects Salmonella in select foods, with negative/presumptive positive results available in approximately 2 hours, post enrichment. Positive confirmation is then possible with an additional 24 hours. The assay can be run manually or with automation by adding Dynex Technologies’ DS-2® system.
Achieving OMA, the highest level of AOAC certification, involved a rigorous certification process that included simultaneous testing at over a dozen labs across the US, UK and South Africa. Data was then closely reviewed by an expert panel confirming result accuracy and repeatability of the Solus One Salmonella assay for a range of samples including raw salmon, romaine lettuce, cheddar cheese, instant non-fat dry milk, pasteurized liquid eggs, raw beef trim, cocoa, and herbs and spices. Tested food sample sizes ranged from 25g to 375g and swabs and sponges for production environment testing were also included.
“The World Health Organization estimates that Salmonella causes over 17 million people to become ill each year globally,” said Greg Sears, vice president and general manager, Food, PerkinElmer. “Members of the food industry, regulatory and research ecosystem around the world need to be able to depend on pathogen testing options that are reliable, consistent and efficient. We are pleased that our Solus One Salmonella assay and methods -- which have already been helping with food safety and quality globally -- have now achieved the highest level of AOAC certification.”
PerkinElmer’s pathogen assay offerings also include Solus One for Listeria and E. coli O157 and are part of the company’s broad food safety and quality solutions portfolio spanning across instruments, software, testing kits, reagents and services for grain, dairy, meats, produce, edible oils, seafood, herbs and spices and more. For more information please visit www.perkinelmer.com/category/food-safety-quality .
PerkinElmer enables scientists, researchers and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, we deliver unique solutions to serve the diagnostics, life sciences, food and applied markets. We strategically partner with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Our dedicated team of about 13,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $2.9 billion in 2019, serves customers in 190 countries, and is a component of the S&P 500 index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com .
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CA-DENODO30.9.2020 08:02:05 CEST | Press release
New Denodo Platform 8.0 Accelerates Hybrid/Multicloud Integration, Automates Data Management with AI/ML, and Boosts Performance
CA-VERIMATRIX30.9.2020 07:17:12 CEST | Press release
Verimatrix Application Shielding Technology Wins CSI Magazine Award
MIRIS30.9.2020 07:02:12 CEST | Press release
Aurora Sustainability: Changing the World With the Network Effect
CELLSAFE30.9.2020 06:46:11 CEST | Press release
CellSafe and Dynasty Castle Investments Limited Signed Distribution Agreement for LAMPlexTM RT-qLAMP COVID-19 Detection Assay
BITFLYER30.9.2020 06:02:05 CEST | Press release
bitFlyer Europe Launches Cross-Border Trading with Japan to Further Consolidate Global Offering
CSTONE-PHARMACEUTICALS30.9.2020 05:24:04 CEST | Press release
CStone, Pfizer Enter into Strategic Collaboration to Address Oncological Needs in China
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom